View in EDS

Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH-Associated Fibrosis.

Saved in:
Bibliographic Details
Title: Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH-Associated Fibrosis.
Authors: Inia JA; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands.; Department of Cardiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, LUMC, Leiden, the Netherlands., Morrison MC; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., van Koppen A; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., Gart E; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., Caspers MPM; Department of Microbiology and Systems Biology, TNO, Leiden, the Netherlands., Menke AL; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., Worms N; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., Kleemann R; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., Verschuren L; Department of Microbiology and Systems Biology, TNO, Leiden, the Netherlands., Jukema JW; Department of Cardiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, LUMC, Leiden, the Netherlands.; Netherlands Heart Institute, Utrecht, the Netherlands., Princen HMG; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., Hanemaaijer R; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands., van den Hoek AM; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, the Netherlands.
Source: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2025 Jun 30; Vol. 39 (12), pp. e70735.
Publication Type: Journal Article
Journal Info: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-6860
DOI:10.1096/fj.202500718R